Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Ovarian Neoplasms 19Breast Neoplasms 18Fallopian Tube Neoplasms 13Neoplasm Metastasis 10Triple Negative Breast Neoplasms 8Prostatic Neoplasms 7Neoplasms 7Endometrial Neoplasms 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neuroendocrine Tumors 3Metastatic Castration-resistant Prostate Cancer 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Sarcoma 2Recurrence 2Pheochromocytoma 2Paraganglioma 2Osteosarcoma 2Neuroblastoma 2Multiple Myeloma 2Medulloblastoma 2Glioma 2Glioblastoma 2Ependymoma 2

Interventions

Specimen Handling 3Taxes 2Carboplatin 2pembrolizumab 1pegfilgrastim 1olaparib 1X-Rays 1Therapeutics 1Radiotherapy 1Radiation 1Panitumumab 1Palliative Care 1Paclitaxel 1Methods 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interviews as Topic 1Indocyanine Green 1Exercise Test 1Epirubicin 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Clostridium perfringens epsilon-toxin 1Albumin-Bound Paclitaxel 1Accelerometry 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × olaparib × 90 days × Clear all
NCT03598257 2026-05-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡